These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2960042)

  • 21. The role of HLA-DQ antigens in the induction of cytotoxic T lymphocytes.
    Porubská S; Buc M; Bencová M; Sausová E
    Folia Biol (Praha); 1993; 39(5):256-61. PubMed ID: 8206171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DR and renal transplantation.
    Morris PJ; Ting A
    Contemp Top Mol Immunol; 1983; 9():65-88. PubMed ID: 6223784
    [No Abstract]   [Full Text] [Related]  

  • 23. Could analysis of helper T-cell precursor frequencies be used as a predictive parameter in renal transplantation?
    Mason PD; Warrens AN; Lechler RI
    Transplant Proc; 1995 Feb; 27(1):230-1. PubMed ID: 7878980
    [No Abstract]   [Full Text] [Related]  

  • 24. Human renal allograft infiltrating T cells: phenotype-function correlation and clonal heterogeneity.
    Miceli MC; Barry TS; Finn OJ
    Transplant Proc; 1988 Apr; 20(2):199-201. PubMed ID: 3284040
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
    Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT
    J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of HLA-DR expression in tubular cells of transplanted kidney for the diagnosis of rejection].
    Almirall J; Solé M; Campistol JM; Bru C; Andreu J
    Med Clin (Barc); 1996 Oct; 107(13):481-5. PubMed ID: 9045012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between HLA-DR mismatch and rejection episodes in cardiac transplantation.
    Pfeffer PF; Foerster A; Frøysaker T; Thorsby E
    Transplant Proc; 1987 Feb; 19(1 Pt 1):691-2. PubMed ID: 3274844
    [No Abstract]   [Full Text] [Related]  

  • 28. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation.
    Kreijveld E; van der Meer A; Tijssen HJ; Hilbrands LB; Joosten I
    Transplantation; 2007 Oct; 84(8):1045-51. PubMed ID: 17989611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of antiglobulin microcytotoxicity test and mixed leukocyte culture to evaluate prognosis in renal transplant recipients.
    Farrow SS; Rossen RD; Suki WN; Hersh EM
    Proc Clin Dial Transplant Forum; 1973; 3():74-6. PubMed ID: 4283133
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejection.
    Shons AR; Etheredge EE; Callender CO; Schmidtke JR; Simmons RL; Najarian JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):464-70. PubMed ID: 4278196
    [No Abstract]   [Full Text] [Related]  

  • 32. Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling.
    Lienert-Weidenbach K; Valiante NM; Brown C; White C; Johnston-Dow L; McGinnis M; Krausa P; Lakes DM; Wolf JL; Blume KG; Parham P
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):255-60. PubMed ID: 9450920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed leukocyte culture reactivity and rejection in renal transplantation in HL-A-identical siblings.
    Etheredge EE; Shons AR; Schmidtke JR; Najarian JS
    Transplantation; 1974 May; 17(5):537-9. PubMed ID: 4275077
    [No Abstract]   [Full Text] [Related]  

  • 34. Allogeneic kidney cells stimulate the production of immunoregulatory cytokines in mixed kidney lymphocyte culture.
    Takahara S; Moutabarrik A; Namiki M; Yamaguchi S; Kameoka H; Ishibashi M; Zaid D; Okuyama A
    Transplant Proc; 1993 Jun; 25(3):2314. PubMed ID: 8516912
    [No Abstract]   [Full Text] [Related]  

  • 35. Prophylactic antilymphocyte globulin and HLA-DR matching reduce the incidence of rejection after cadaveric kidney transplantation.
    Weimar W; Hendriks GF; Wenting GJ; Vincent HH; Schreuder GM; Jeekel J
    Transplant Proc; 1987 Oct; 19(5):3612-3. PubMed ID: 3313869
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytotoxic cells may not be responsible for renal allograft rejection.
    Quigley RL; Wood KJ; Morris PJ
    Transplant Proc; 1988 Aug; 20(4):681-3. PubMed ID: 2970143
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantitation of soluble forms of HLA in kidney transplantation.
    Shimura T; Hagihara M; Yamamoto K; Takebe K; Munkhbat B; Tsuji K
    Transplant Proc; 1994 Aug; 26(4):1891. PubMed ID: 8066614
    [No Abstract]   [Full Text] [Related]  

  • 38. Amplification of in vitro tissue-associated (mixed lymphocyte kidney culture) immunity by allograft rejection.
    Miller J; Esquenazi V; Olson L; Roth D; Milgrom M; Fuller L
    Transplant Proc; 1987 Feb; 19(1 Pt 1):263-4. PubMed ID: 2978902
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship of mixed lymphocyte culture response, HL-A histocompatibility antigens, and renal transplantation.
    Thompson JS; Flink RJ; Caldwell JL; Severson CD; Bonney WW
    Transplant Proc; 1973 Dec; 5(4):1763-9. PubMed ID: 4130081
    [No Abstract]   [Full Text] [Related]  

  • 40. The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.
    Smith AY; Van Buren CT; Lewis RM; Kerman RH; Welsh M; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):180-93. PubMed ID: 3291239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.